Related content

Identification of a hepatitis C virus mutant lacking the hypervariable region 1 in a chronically infected patient non-responding to PEG-interferon-α/ribavirin therapy

By Kmieciak D.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 28, Iss. 2, 2009-02 ,pp. : 211-213

Springer Publishing Company

Access to resources Recommend Favorite

Voriconazole Proves Effective in Long-Term Treatment of a Cerebral Cryptococcoma in a Chronic Nephropathic HIV-Negative Patient, after Fluconazole Failure

By Sabbatani S.   Manfredi R.   Pavoni M.   Consales A.   Chiodo F.  

Mycopathologia, Vol. 158, Iss. 2, 2004-09 ,pp. : 165-171

Springer Publishing Company

Access to resources Recommend Favorite

Predictors for dose reduction of antiviral therapy in older patients infected with hepatitis C virus: a meta-regression analysis

By Zhou H.   Luo H.   Xiao S.   Wang H.   Gong G.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 33, Iss. 4, 2014-04 ,pp. : 491-498

Springer Publishing Company

Access to resources Recommend Favorite

Hepatitis C virus quasispecies populations during chronic hepatitis C infection

By Enomoto N.   Sato C.  

Trends in Microbiology, Vol. 3, Iss. 11, 1995-11 ,pp. : 445-447

Elsevier

Access to resources Recommend Favorite

Hepatitis C virus infection among First Nation and non-First Nation people in Manitoba, Canada — a public health laboratory study

By Dawood Magdy   Smart Gerry   Wood Michelyn   Wu Hong-Xing   Paton Shirley   Wu Jun  

Canadian Journal of Microbiology, Vol. 52, Iss. 10, 2006-10 ,pp. : 999-1005

NRC Research Press

Access to resources Recommend Favorite